Treatment of children with atopic dermatitis (AD) with 1% SDZ ASM 981 cream (ASM)

被引：0
|
作者：
Boguniewicz, M
Leung, DYM
Marshall, K
Bush, C
Graeber, M
Cherill, R
机构：
[1] Natl Jewish Med & Res Ctr, Denver, CO USA
[2] Novartis Pharmaceut Corp, E Hanover, NJ USA
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2001年 / 107卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
1009
引用
收藏
页码：S308 / S308
页数：1
相关论文
共 50 条
  • [1] First experience of topical SDZ ASM 981 in children with atopic dermatitis
    Harper, J
    Green, A
    Scott, G
    Gruendl, E
    Dorobek, B
    Cardno, M
    Burtin, P
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) : 781 - 787
  • [2] SDZ-ASM-981 Pimecrolimus Elidel® -: Treatment of atopic dermatitis
    不详
    DRUGS OF THE FUTURE, 2000, 25 (05) : 539 - 539
  • [3] SDZ ASM 981: an emerging safe and effective treatment for atopic dermatitis
    Luger, T
    Van Leent, EJM
    Graeber, M
    Hedgecock, S
    Thurston, M
    Kandra, A
    Berth-Jones, J
    Bjerke, J
    Christophers, E
    Knop, J
    Knulst, AC
    Morren, M
    Morris, A
    Reitamo, S
    Roed-Petersen, J
    Schoepf, E
    Thestrup-Pedersen, K
    Van der Valk, PGM
    Bos, JD
    BRITISH JOURNAL OF DERMATOLOGY, 2001, 144 (04) : 788 - 794
  • [4] SDZ ASM 981 cream 1%: A new approach to long-term management of atopic dermatitis
    Wahn, U
    Molloy, S
    Graeber, M
    Thurston, M
    Cherill, R
    de Prost, Y
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 533 - 533
  • [5] Pimecrolimus -: SDZ-ASM-981 -: Elidel® -: Treatment of atopic dermatitis -: Antipsoriatic
    不详
    DRUGS OF THE FUTURE, 2001, 26 (05) : 508 - 511
  • [6] Effectiveness of the ascomycin macrolactam SDZ ASM 981 in the topical treatment of atopic dermatitis
    Van Leent, EJM
    Gräber, M
    Thurston, M
    Wagenaar, A
    Spuls, PI
    Bos, JD
    ARCHIVES OF DERMATOLOGY, 1998, 134 (07) : 805 - 809
  • [7] SDZ ASM 981
    Keri Wellington
    Caroline M. Spencer
    BioDrugs, 2000, 14 : 409 - 416
  • [8] SDZ ASM 981
    Wellington, K
    Spencer, CM
    BIODRUGS, 2000, 14 (06) : 409 - 416
  • [9] SDZ ASM 981 Cream 1% is efficacious and safe in infants aged 3-23 months with atopic dermatitis
    Ho, V
    Hedgecock, S
    Bush, C
    Marshall, K
    Thurston, M
    Graeber, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 532 - 532
  • [10] Safety and efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents
    Eichenfield, LF
    Lucky, AW
    Boguniewicz, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2002, 46 (04) : 495 - 504
12345